David Bernstein

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy et al. · New England Journal of Medicine · 2014 · 1.1K citations · Full text

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients

Ira M. Jacobson, Robert S. Brown, Bradley Freilich et al. · Hepatology · 2007 · 306 citations · Full text

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

Kris V. Kowdley, Eric Lawitz, Israel Crespo et al. · The Lancet · 2013 · 296 citations

Hepatitis C, Multicentre Phase 2, Viral Hepatitis +8

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

David Bernstein, Leah Kleinman, Chris M. Barker et al. · Hepatology · 2002 · 230 citations · Full text

Family Medicine, Quality Of Life, Life Assessment +18

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure

Fred Poordad, Stanislas Pol, Armen Asatryan et al. · Hepatology · 2017 · 136 citations · Full text